WASHINGTON DC – The United States will share with the rest of the world its reserves of the COVID-19 vaccine created by the pharmaceutical company AstraZeneca, which has not yet been approved in the country, the White House reported Monday.
Up to 60 million doses are expected to be available for export in the coming months, he said. Andy Slavitt, advisor to the federal government team that carries out the strategy to eradicate the virus in the US.
The move greatly expands the Biden administration’s decision in March to share about 4 million doses of the vaccine with Mexico and Canada.
AstraZeneca’s vaccine is widely used around the world, but is not yet licensed by the Food and Drug Administration (FDA).
Over the weekend, US regulators cleared the resumption of Johnson & Johnson’s single-dose injection.
More than 3 million people worldwide have died from COVID-19 since the start of the pandemic.